22 results
8-K
EX-10.2
XLO
Xilio Therapeutics Inc
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
”) and that none of the Investors is an “underwriter.” The Investors shall have the right to select one legal counsel to review and oversee any
10-K
vyj1j
1 Mar 22
Annual report
4:07pm
10-Q
nwjrv30phjdu
2 Dec 21
Quarterly report
4:15pm
424B4
v48ucodmt98bu
22 Oct 21
Prospectus supplement with pricing info
4:02pm
S-1/A
19av oaxvh
18 Oct 21
IPO registration (amended)
6:04am
S-1
EX-10.11
dt7 le5y6
1 Oct 21
IPO registration
4:49pm
S-1
3hyhdrirzo1e
1 Oct 21
IPO registration
4:49pm
S-1
EX-10.9
bxxptw8n1g79
1 Oct 21
IPO registration
4:49pm
DRS/A
sxt8rqorc kd
14 Sep 21
Draft registration statement (amended)
12:00am